← Eichor
Condition: Autoimmune Inflammatory Rheumatic Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Autoimmune Inflammatory Rheumatic Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT03913962Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, a
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT03510442Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-medi
Phase N/A · 4 location(s) · Meyer Children's Hospital IRCCS · NCT06862843Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
Phase N/A · 1 location(s) · University of Bonn · NCT06460142Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Peking University Third Hospital · NCT06828042Biobank for Inflammatory Chronic Diseases and Osteoporosis
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05039216Oxidative Stress in Autoimmune Rheumatic Diseases
Phase N/A · 1 location(s) · University of Thessaly · NCT07536529A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants Wit
Phase 1 · 37 location(s) · AstraZeneca · NCT06916806A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Phase 1 · 19 location(s) · GlaxoSmithKline · NCT07371468Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06339177Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
Phase 2 · 1 location(s) · University Medical Center Groningen · NCT03938701Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
Phase 1 · 9 location(s) · Sonoma Biotherapeutics, Inc. · NCT06201416Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
Phase N/A · 1 location(s) · University of Michigan · NCT00748254A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT06978647Biomarkers in Inflammatory Rheumatic Diseases Diagnosis
Phase N/A · 1 location(s) · Universidade Nova de Lisboa · NCT06778343A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Disease
Phase 1 · 28 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT07115745Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammat
Phase 4 · 1 location(s) · Tongji Hospital · NCT06499233An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
NA · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT06379646Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Diseas
Phase N/A · 1 location(s) · Hospital Universitario Araba · NCT07249060Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620Regulation of Mucosal Healing in Inflammatory Bowel Disease
NA · 1 location(s) · Terrence A Barrett · NCT04504136Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT06842316REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Phase 4 · 7 location(s) · Sint Maartenskliniek · NCT07160231Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PRE
Phase 4 · 17 location(s) · Instituto de Investigación Marqués de Valdecilla · NCT07611747Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT03759522MTS109 in Patients With Refractory Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Shanghai Changzheng Hospital · NCT07526350Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT07065747A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
Phase 1 · 1 location(s) · Xencor, Inc. · NCT07284797ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06593041Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Phase 1 · 2 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT07236801
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.